GSK unveils separation plan for Consumer Healthcare

24 June 2021 - Deborah Wilkes

Premium

GlaxoSmithKline (GSK) has confirmed plans to demerge its Consumer Healthcare business in mid 2022. The company says New Consumer Healthcare will have 20 brands each with sales in excess of GBP100 million (USD140 million).

Click tags below for more information on topics:

GlaxoSmithKline

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: